Delivery Order SPE2DB22D2206-SPE2DB26FDV50
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract valued at $4,335.66. The order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a small-value pharmaceutical procurement without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $6,477.04 under a firm fixed-price contract type. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $2,464.20. This is a firm fixed-price, non-set-aside delivery order awarded on October 22, 2025, with an ultimate completion date of October 23, 2025. The order is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30, with a ceiling value of $2,347.10. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,982.61 on July 30, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $4,107.42. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $5,344.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). The contract, which is classified as a non-set-aside award, is scheduled for completion by October 20, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 10, with a contract ceiling value of $1,688.16. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for ultimate completion by June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,584.30 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDV50Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) valued at $8,013.86. The contract was executed on October 30, 2025, with an ultimate completion date of October 31, 2025, and employs firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle extending through December 2026. The IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded contracts through the DLA demonstrates its capability to meet rigorous federal procurement standards for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/30/25 |